Clinical Trial Update: Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial studying ZN-d5 and ZN-c3 in acute myeloid leukemia was terminated; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ZN-c3
• ZN-d5

Snippet

Sponsor: K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | Conditions: Acute Myeloid Leukemia (AML) | Phase 1, Phase 2 | Status: TERMINATED